Literature DB >> 34523281

[Effectiveness of synchronous unilateral percutaneous kyphoplasty in the treatment of double noncontiguous thoracolumbar osteoporotic vertebral compression fractures].

Weili Jiang1, Guoqi Niu1, Gong Zhou1, Tao Liu1, Qingbo Zhang1, Lutan Liu1, Jiawei Cheng1.   

Abstract

OBJECTIVE: To investigate the effectiveness of synchronous unilateral percutaneous kyphoplasty (PKP) in the treatment of double noncontiguous thoracolumbar osteoporotic vertebral compression fracture (OVCF).
METHODS: Between December 2018 and September 2020, 27 patients with double noncontiguous thoracolumbar OVCF were treated by synchronous unilateral PKP. There were 11 males and 16 females, with an average age of 75.4 years (range, 66-92 years). The fractures were caused by falls in 22 cases and sprains in 5 cases. The time from injury to hospital admission was 0.5-7.0 days, with an average of 2.1 days. The fractured vertebrae located at T 9 in 2 cases, T 10 in 3 cases, T 11 in 10 cases, T 12 in 15 cases, L 1 in 12 cases, L 2 in 6 cases, L 3 in 4 cases, and L 4 in 2 cases. The volume of bone cement injected into each vertebral body, operation time, and intraoperative fluoroscopy times were recorded. Anteroposterior and lateral X-ray films of thoracolumbar spine were taken to observe the anterior height of the injured vertebra, the Cobb angle of kyphosis, and the diffusion and good distribution rate of bone cement in the thoracolumbar spine. Visual analogue scale (VAS) score and Oswestry disability index (ODI) were used to evaluate the pain and functional improvement.
RESULTS: All operations completed successfully. The operation time was 34-70 minutes, with an average of 45.4 minutes. The intraoperative fluoroscopy was 21- 60 times, with an average of 38.6 times. The volume of bone cement injected into each vertebral body was 2-9 mL, with an average of 4.3 mL. All patients were followed up 6-21 months, with an average of 11.3 months. X-ray film reexamination showed that the anterior height of the injured vertebra and Cobb angle at each time point after operation were significantly improved than those before operation ( P<0.05), and there was no significant difference between different time points after operation ( P>0.05). The distribution of bone cement was excellent in 40 vertebral bodies, good in 13 vertebral bodies, and poor in 1 vertebral body, and the excellent and good rate was 98.1% (53/54). The pain of all patients significantly relieved or disappeared, and the function improved. The VAS score and ODI at each time point after operation were significantly lower than those before operation ( P<0.05), and there was no significant difference between different time points after operation ( P>0.05).
CONCLUSION: For the double noncontiguous thoracolumbar OVCF, the synchronous unilateral PKP has the advantages of simple puncture, less trauma, less intraoperative fluoroscopy, shorter operation time, satisfactory distribution of bone cement, etc. It can restore the height of the vertebral body, correct the kyphotic angle, significantly alleviate the pain, and improve the function.

Entities:  

Keywords:  Percutaneous kyphoplasty; osteoporotic vertebral compression fracture; unilateral puncture

Mesh:

Substances:

Year:  2021        PMID: 34523281      PMCID: PMC8444143          DOI: 10.7507/1002-1892.202103018

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  10 in total

Review 1.  Vertebroplasty and kyphoplasty.

Authors:  Douglas A Linville
Journal:  South Med J       Date:  2002-06       Impact factor: 0.954

2.  Percutaneous balloon kyphoplasty in the treatment of painful vertebral compression fractures: effect on local kyphosis and one-year outcomes in pain and disability.

Authors:  Krzysztof Zapałowicz; Maciej Radek
Journal:  Neurol Neurochir Pol       Date:  2014-12-02       Impact factor: 1.621

Review 3.  Risk factors for new vertebral compression fractures after percutaneous vertebroplasty: qualitative evidence synthesized from a systematic review.

Authors:  XinLong Ma; Dan Xing; JianXiong Ma; Jie Wang; Yang Chen; WeiGuo Xu; Yang Yang; BaoYi Ma; ShaoWen Zhu
Journal:  Spine (Phila Pa 1976)       Date:  2013-05-20       Impact factor: 3.468

4.  Vertebroplasty, Kyphoplasty, Lordoplasty, Expandable Devices, and Current Treatment of Painful Osteoporotic Vertebral Fractures.

Authors:  Mohamed El-Fiki
Journal:  World Neurosurg       Date:  2016-04-09       Impact factor: 2.104

5.  Initial outcome and efficacy of "kyphoplasty" in the treatment of painful osteoporotic vertebral compression fractures.

Authors:  I H Lieberman; S Dudeney; M K Reinhardt; G Bell
Journal:  Spine (Phila Pa 1976)       Date:  2001-07-15       Impact factor: 3.468

6.  Elevated alpha-fetoprotein and human chorionic gonadotropin as a marker for placental trisomy 16 in the second trimester?

Authors:  R Zimmermann; U Lauper; A Streicher; R Huch; A Huch
Journal:  Prenat Diagn       Date:  1995-12       Impact factor: 3.050

7.  Predictors of outcomes of percutaneous vertebroplasty for osteoporotic vertebral fractures.

Authors:  Luis Alvarez; Antonio Pérez-Higueras; Juan J Granizo; Ignacio de Miguel; Diana Quiñones; Roberto E Rossi
Journal:  Spine (Phila Pa 1976)       Date:  2005-01-01       Impact factor: 3.468

8.  Does a fracture liaison service program minimize recurrent fragility fractures in the elderly with osteoporotic vertebral compression fractures?

Authors:  Tarik Wasfie; Avery Jackson; Caramarie Brock; Stefanija Galovska; Jennifer R McCullough; Jacob A Burgess
Journal:  Am J Surg       Date:  2018-09-22       Impact factor: 2.565

9.  Comparison of percutaneous balloon dilation kyphoplasty and percutaneous vertebroplasty in treatment for thoracolumbar vertebral compression fractures.

Authors:  K-Z Hu; S-C Chen; L Xu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-07       Impact factor: 3.507

10.  Descemet stripping automated endothelialkeratoplasty (DSAEK) versus repeat penetrating keratoplasty (PKP) to manage eyes with failed corneal graft.

Authors:  Abdulrahman Khairallah
Journal:  Ann Saudi Med       Date:  2018 Jan-Feb       Impact factor: 1.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.